Jianting Sheng

Jianting Sheng

UNVERIFIED PROFILE

Are you Jianting Sheng?   Register this Author

Register author
Jianting Sheng

Jianting Sheng

Publications by authors named "Jianting Sheng"

Are you Jianting Sheng?   Register this Author

18Publications

648Reads

10Profile Views

Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.

Cancer Lett 2020 Jan 28;469:195-206. Epub 2019 Oct 28.

Center for Modeling Cancer Development, Houston Methodist Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2019.10.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905085PMC
January 2020

Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.

Clin Cancer Res 2019 Nov 22;25(21):6417-6428. Epub 2019 Jul 22.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825539PMC
November 2019

Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.

J Natl Cancer Inst 2019 Mar;111(3):272-282

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410941PMC
March 2019

The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.

Mol Ther Nucleic Acids 2019 Mar 13;14:301-317. Epub 2018 Dec 13.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omtn.2018.11.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348737PMC
March 2019

Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.

Cancer Res 2018 04 22;78(8):2052-2064. Epub 2018 Mar 22.

Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-2994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899649PMC
April 2018

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.

J Clin Invest 2018 02 18;128(2):589-606. Epub 2017 Dec 18.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI95200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785271PMC
February 2018

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Nature 2015 Nov 11;527(7579):472-6. Epub 2015 Nov 11.

Department of Cardiothoracic Surgery, Weill Cornell Medical College of Cornell University, 1300 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature15748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662610PMC
November 2015

Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition.

Oncotarget 2015 Sep;6(28):25320-38

Department of Systems Medicine and Bioengineering, Houston Methodist Research Institute, Weill Cornell Medical College, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694834PMC
September 2015

Optimal drug prediction from personal genomics profiles.

IEEE J Biomed Health Inform 2015 Jul 13;19(4):1264-70. Epub 2015 Mar 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1109/JBHI.2015.2412522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532321PMC
July 2015

Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model.

Cell Rep 2015 Feb 19;10(7):1187-201. Epub 2015 Feb 19.

Department of Cardiothoracic Surgery, Weill Cornell Medical College of Cornell University, 1300 York Avenue, 525 East 68(th) Street, New York, NY 10065, USA; Department of Cell and Developmental Biology, Weill Cornell Medical College of Cornell University, 1300 York Avenue, 525 East 68(th) Street, New York, NY 10065, USA; Neuberger Berman Lung Cancer Center, Weill Cornell Medical College of Cornell University, 1300 York Avenue, 525 East 68(th) Street, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.01.040DOI Listing
February 2015

DrugComboRanker: drug combination discovery based on target network analysis.

Bioinformatics 2014 Jun;30(12):i228-36

Department of Information Science, School of Mathematical Sciences and LMAM, Peking University, Beijing, 100871, China and NCI Center for Modeling Cancer Development, Department of Systems Medicine and Bioengineering, Houston Methodist Hospital Research Institute; Weill Cornell Medical College of Cornell University, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btu278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058933PMC
June 2014

Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.

Mol Cancer Ther 2014 May 16;13(5):1142-54. Epub 2014 Jan 16.

Authors' Affiliations: Houston Methodist Research Institute, Houston, Texas; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0770DOI Listing
May 2014